Skip to content
BOE-A-2026-9353 ·29 April 2026 ·Resolution Low impact
Administrative

Dissolution of the Advisory Committee on Growth Hormone and Related Substances

The Directorate General for the Common Portfolio of Services of the National Health System and Pharmacy has declared the Advisory Committee on Growth Hormone and Related Substances dissolved. This resolution repeals the resolutions of 29 March 1989 and 28 May 1991, acting in accordance with Article 5 of Royal Decree 718/2024.

In 2 key points

  1. Dissolution of the Advisory Committee on Growth Hormone and Related Substances (Resolución de 17 de abril de 2026)
  2. Repeal of the resolutions of 29 March 1989 and 28 May 1991 (ref. indice BOE)

How it affects those involved

This measure does not create operational changes for companies, the self-employed, or individuals, as it is an internal administrative resolution suppressing a consultative body of the Ministry of Health. The effect is purely organisational within the Health Administration.

Lifecycle

2026-04-29PublishedPublished in the BOE
Official text Based on BOE data (boe.es). Information, not advice.

Does this provision affect you?

The administrative team reviews your specific situation.

Talk to the administrative team
This analysis is informational only and does not constitute legal advice or create a client-adviser relationship. BM Consulting.
Email
Contact